SOURCE: Industrial Info Resources

Industrial Info Resources

April 25, 2012 06:40 ET

Vaccines' Allure Remains Solid for Pharma, Attracting $2.5 Billion in North American Capital Investment, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwire - Apr 25, 2012) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Vaccines continue to attract the drug industry for the same reasons as they always have. The vaccines sector is a darling in that there always seems to be some government funding involved. That particular flow has been staunched a bit, but this is not expected to last, as the clamor for vaccines never really dissipates. By the end of 2012, the global vaccine market is expected to hit $34 billion in sales. With an estimated annual growth rate of 14% during the next five years, it is believed that vaccines will be the fastest growing therapeutic area, eventually outpacing oncology.

Companies featured: Merck (NYSE:MRK), GlaxoSmithKline (NYSE:GSK), Sanofi Pasteur (NASDAQ:SNY), Pfizer (NYSE:PFE), Novartis (NASDAQ:NVS)

For details, view the entire article by subscribing to Industrial Info's Premium Industry News at, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, and eight offices outside of North America, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    Joe Govreau